Institute news

  • Congratulations to Karolina Cyll

    11.11.2020 portrait Karolina Cyll

    Karolina Cyll came to the ICGI as a MSc student in 2011, where her project entailed reviewing and  increasing the efficiency of the ploidy preparation lab procedure.

    In December 2020 she defended her thesis for the PhD degree, titled “High-resolution, high-throughput nuclear analysis as a prognostic marker in prostate cancer.”  The study was dedicated to finding prognostic markers for patients with early and intermediate stage of prostate cancer. Investigated material comprised of formalin-fixed paraffin-embedded prostate tumor tissue from radical prostatectomies as well as biopsy materials from patients under surveillance. The main focus was genomic instability, resistance to cell death and immortality of cancer cells. The employed methods were DNA ploidy, nucleotyping, immunohistochemistry and FISH.

    We are happy Karolina will continue at our Institute as Post.doc

  • Andreas Kleppe appointed Associate Professor at University of Oslo

    11.11.2020 andreas Kleppe portrait

    We are so proud of the institutes' many young researchers and pleased to see everything they achieve. Congratulations to Post Doc Andreas Kleppe on his position as Associate Professor at the University of Oslo, Department of Informatics.

    The position will involve teaching in image processing, image analysis and deep learning, as well as supervision of master's degree students and doctoral students. Andreas defended his dissertation in 2017 and was the year after the first author of the widely acclaimed article Chromatin organization and cancer prognosis: a pan-cancer study https://www.thelancet.com/.../PIIS1470-2045(17.../fulltext. We wish Andreas good luck with his new, exciting tasks!


  • The amount of stroma - a new prognostic marker for cancer?


    Solid tumours contain many different cellular components in addition to tumour cells. The stroma is the supportive framework of an organ, usually composed of connective tissue, distinguished from the cells or tissues performing the special function of the organ. The manual assessment of the amount of reactive stroma has been shown, by us and others, to be a prognostic marker in both colorectal cancer and prostate cancer. This video describes how to perform an automated analysis of tumour stroma content using routine diagnostic H&E stained tissue sections. Stroma can be combined with DNA ploidy to identify patients at increased risk for poor outcome. The DNA Ploidy and Stroma biomarker are based on a research collaboration between ICGI and professor David Kerr and the University of Oxford.

  • AI benefits colorectal cancer patients


    Professor David Kerr at Oxford University talks about the possible benefits for cancer patients, following the article "Deep learning for prediction of colorectal cancer outcome: a discovery and validation study" , published in "The Lancet" on February 1st 2020.



  • Marco Novelli on the ICGI Lancet article


    Our research colleague based at the University of London, Professor Marco Novelli, talks about his excitement for the results presented in the Lancet article published in February 2020. The article was authored by researchers from ICGI, University of Oslo and colleagues in the UK.



  • ICGI's Lancet article presented at Oslo Life Science 2020


    The ICGI recently developed a clinically useful prognostic marker using deep learning and digital scanning of conventional hematoxylin and eosin-stained tumor tissue sections. The assay has been extensively evaluated in large, independent patient populations, correlates with and outperforms established molecular and morphological prognostic markers, and gives consistent results across tumor and nodal stage.

    The article "Deep learning for prediction of colorectal cancer outcome: a discovery and validation study" was published in "The Lancet" on February 1st 2020, and has since been presented on several occasions. One of them was at the conference "Oslo Life Science 2020", held in the amazing "Aula" of, and by, the University of Oslo, where among others the newly appointed Director of Oslo University Hospital; Bjørn-Atle Bjørnbeth, attended. He congratulated Håvard Danielsen, Ole-Johan Skrede, Sepp De Raedt and the other co-authors with their excellent achievement.

    Please click here to download and read the article in The Lancet (free).

    We call the method Histotyping or the CRC-v1-Network, to learn more about the Histotyping project, click here.



  • ICGI at the Norwegian Oncology Forum 2019


    The 2019 Oncology Forum was held in Tromsø, 20th - 22nd November. 450 participants from different parts of Norway were present to hear updates on oncology treatments and reseach. Fridays program announced Professor Håvard E. Danielsen to speak on AI and Digital pathology. Danielsen presented the DoMore!-project (www.domore.no) and appealed for even more reseach materials from the audience.

  • HED @ HOD


    On tuesday 29th October 2019, HOD; Helse- og omsorgsdepartementet (Ministry of Health and Care Services) held a Conference to launch the National Health and Hospital Plan, the overall document for the Norwegian specialist health service. 

    One of the main topics this year was technology. Head of Department Håvard E. Danielsen presented the research project www.domore.no, demonstrating how www.icgi.no uses artificial intelligence for better prediction of cancer. The presentation was streamed to a large audience.

    For more about the domore!-project, please click here.

    Håvard Danielsen presenting the DoMore! project at the Conference launcing the National Health and Hospital Plan 

  • Congratulations from near and far


    Watch the video with greetings from some of our affiliated researchers, clinicians and other collaborators. The video was made

  • The ICGI is 15!

    22.08.2019 ICGI anniversary logo

    The Institute for Cancer Genetics and Informatics is celebrating its 15th anniversary. Presentations at the annual summer seminar showed that the institute has reached many goals the last fifteen years, and will continue the search for improved cancer prognostics and diagnostics also in the future.

    We congratulate the recipients of this year's ICGI awards, presented by Institute leader Håvard E. Danielsen

    • Senior researcher Birgitte Nilsen received the research award for her excellent work on chromatin entropy and prognosis.
    • PhD candidate Ole Johan Skrede and Post. Doc Sepp de Raedt received the development award.
    • Post. Doc Andreas Kleppe got the award for high efforts.
    • Professor Sverre Heim at Section for Cancer Cytogenetic received the honorary award.
    • Head Engineer Wanja Kildal received the prize for best social initiative.

    Several other employees' efforts were also highlighted during a long day with a high dose of professional content wrapped in various forms of festivities.

    Photos: Manohar Pradhan

    Birgitte Nielsen mottar IKIs forskningspris fra Håvard Danielsen Sepp de Raedt and Ole Johan Skrede receiving the ICGI Development Prize 2019 from Håvard E. Danielsen
    Andreas Kleppe receiving the ICGI High Efforts Award 2019 from Håvard E. Danielsen Sverre Heim, ICGI Honorary Reward 2019
    Wanja Kildal, Social Initative Award, ICGI, 2019
Chief Editor: Prof. Håvard E. Danielsen
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20